Cimlanod
- Generic Name
- Cimlanod
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C5H7NO4S
- CAS Number
- 1620330-72-4
- Unique Ingredient Identifier
- 2US4FK1EPV
- Background
Cimlanod is under investigation in clinical trial NCT02819271 (A First-in-Human Study of the Safety of Single Continuous Intravenous (IV) Infusions of CXL-1427 for up to 48 Hours in Healthy Volunteers).
- Associated Conditions
- -
- Associated Therapies
- -
An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic
- Conditions
- Interventions
- First Posted Date
- 2018-11-05
- Last Posted Date
- 2021-02-26
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 23
- Registration Number
- NCT03730961
- Locations
- π¬π§
Richmond Pharmacology, London, United Kingdom
π¬π§Glasgow Clinical Research Facility, Glasgow, United Kingdom
An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function
- Conditions
- Interventions
- First Posted Date
- 2018-05-04
- Last Posted Date
- 2020-08-27
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 76
- Registration Number
- NCT03515980
- Locations
- π΅π±
KO-MED Centra Kliniczne Lublin, Lublin, Poland
ππΊSemmelweis Egyetem Altalanos Orvostudomanyi Kar, Budapest, Hungary
π΅π±BioVirtus Centrum Medyczne, Jozefow, Poland
A Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney Function
- Conditions
- Interventions
- First Posted Date
- 2017-11-06
- Last Posted Date
- 2019-09-11
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 48
- Registration Number
- NCT03332186
- Locations
- π¨πΏ
Local Institution, Praha 7, Czechia
π΅π±Samodzielny Publiczny Secjalistyczny Szpital Zachodni im. sw. Jana Pawla II, Grodzisk Mazowiecki, Poland
π΅π±Specjalistyczne Centrum Medyczne Panacea Poznan, Krakow, Poland
Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male Participants
- First Posted Date
- 2017-07-07
- Last Posted Date
- 2017-08-01
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 5
- Registration Number
- NCT03210909
- Locations
- πΊπΈ
Covance Clinical Research Unit, Madison, Wisconsin, United States
Study With Healthy Japanese and Non-Asian Participants With BMS-986231
- Conditions
- Interventions
- First Posted Date
- 2016-10-13
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 56
- Registration Number
- NCT02932969
- Locations
- πΊπΈ
West Coast Clinical Trials, Llc, Cypress, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.